Back to Journals » OncoTargets and Therapy » Volume 9 » Two-gene signature improves the discriminatory power of IASLC/ATS/ERS classification to predict the survival of patients with early-stage lung adenocarcinoma
Please verify you are not a robot.
Back to Journals » OncoTargets and Therapy » Volume 9 » Two-gene signature improves the discriminatory power of IASLC/ATS/ERS classification to predict the survival of patients with early-stage lung adenocarcinoma
Please verify you are not a robot.